Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, 7 February 2015, Vol 294, No 7848

Sort by: Newest first Oldest first A-Z Z-A

  • In January 2014, the European Medicines Agency (EMA) approved a combination hepatitis C treatment. However, it costs over US$80,000 for a 12-week course

    Rolling out hepatitis C treatments will be costly Subscription

    5 FEB 2015 15:00

    The new generation of heptatitis C antivirals is highly effective, but the drugs’ expense will put pressure on healthcare providers.

  • A range of anti-smoking policies and new cessation products has led to reduced rates of smoking in most countries, which will eventually impact on smoking-related deaths.

    A decade of smoking cessation in Europe Subscription

    5 FEB 2015 By Dawn Connelly

    The continent with the worst smoking habit is gradually giving it up. A range of anti-smoking policies and new cessation products has led to reduced rates of smoking in most countries, which will eventually impact on smoking-related deaths.

  • The Royal Pharmaceutical Society (RPS) will expand practice assessments that will allow pharmacists with two to 10 years experience to gain Faculty accreditation in April this year

    RPS offers first Faculty assessments to pharmacists with two years’ experience Subscription

    5 FEB 2015 14:46 By Stephen Robinson
    Comments (1)

    In April 2015, the Royal Pharmaceutical Society (RPS) Faculty will consider applications for membership from pharmacists with at least two years’ post-registration experience for the first time, it has been announced.

  • A randomised trial involving 91 children undergoing tonsillectomy has highlighted safety concerns with morphine for pain management after surgery

    Study highlights safety concerns over morphine use after tonsillectomy Subscription

    5 FEB 2015 14:45
    Comments (1)

    New research suggests that morphine should not be used for post-operative pain in children, as it may be unsafe in some children.

  • Ash Soni, RPS President

    RPS president: becoming a royal college would give us greater gravitas Subscription

    5 FEB 2015 11:52 By Stephen Robinson

    Six months into the role, Royal Pharmaceutical Society (RPS) President Ash Soni talks to Stephen Robinson about how the Society could become a royal college and why pharmacists will come to be seen as the ‘glue’ holding together the NHS and social care.

  • Women who have used oral contraceptives have an increased risk of developing glioma, a rare brain tumour, new research finds

    Oral contraceptives linked with increased risk of brain tumours Subscription

    5 FEB 2015 11:07

    Women who have ever used oral contraceptives have an increased risk of developing glioma – a rare brain tumour – compared with the general population, according to new research.

  • Foods high in salt, sugar and fat should be taxed to discourage unhealthy eating and slow rates of childhood obesity

    A tax on junk food is the way to fight the childhood obesity crisis Subscription

    5 FEB 2015 11:03 By Colin Michie
    Comments (1)

    Foods high in salt, sugar and fat should be taxed to discourage unhealthy eating and slow rates of childhood obesity, says Colin Michie.

  • Recent research shows that interleukin-10 (pictured), an anti-inflammatory cytokine, actually increased the deposition of apolipoprotein E protein in a mouse model of Alzheimer's disease

    Research challenges ‘cytokine storm’ hypothesis of Alzheimer’s disease Subscription

    4 FEB 2015 16:28

    Interleukin-10 – an anti-inflammatory cytokine – has detrimental effects in a mouse model of Alzheimer’s disease (AD), challenging the “cytokine storm” hypothesis of AD progression.

  • Still not convinced pharmacy student numbers should be capped Subscription

    4 FEB 2015 12:06 By Barry Shooter
    Comments (1)

    In 2013 I explained in detail why I am in favour of market forces determining the number of students entering the MPharm course (The Pharmaceutical Journal 2013;291:246) rather than a cap being applied.

  • Ravi Sharma, senior primary care pharmacist and quality assurance lead

    Helping newly registered pharmacists to work in general practice Subscription

    4 FEB 2015 10:59 By Ravi Sharma

    Newly registered pharmacists have been given the opportunity to work with GPs in southern England as part of a programme run by a consortium of GP surgeries. Ravi Sharma, senior primary care pharmacist and quality assurance lead, explains how the programme was set up and what it has achieved.

  • Sydney Crowther dies Subscription

    3 FEB 2015 14:05

    On 19 January 2015, Sydney Crowther MRPharmS, aged 95, of Maddington Place, Shrewton, Salisbury SP3 4JE. Mr Crowther registered with the Society in 1942.

  • MRI brain scan that shows the temporal lobe. An analysis of 129 people with temporal lobe epilepsy and found that genetic control of convulsions was due to a single gene, Sestrin 3 (SESN3)

    Sestrin 3 gene regulates convulsions in epilepsy Subscription

    3 FEB 2015 14:03

    Researchers analysed hippocampal brain tissue samples from 129 people with temporal lobe epilepsy and found that genetic control of convulsions was due to a single gene.

  • Tribute to Sydney Crowther Subscription

    3 FEB 2015 13:56 By Alison Ewing

    When Sydney Crowther passed away on 19 January 2015 at the fine age of 95, it was the end of an era for pharmacy. He was a remarkable man and a passionate “old-school” pharmacist.

  • Anti-VEGF (vascular endothelial growth factor) therapies could help treat tuberculosis, research finds. In the image, SEM of tuberculosis bacteria.

    Anti-VEGF therapies could have role in treating TB Subscription

    3 FEB 2015 13:28

    Bevacizumab, an anti-VEGF drug, was able to normalise granuloma vasculature, improve the delivery of small molecules and decrease hypoxia in a rabbit model of tuberculosis.

  • Pharmacy support for carers

    3 FEB 2015 13:27

    The Pharmaceutical Services Negotiating Committee (PSNC) has produced a resouce to help community pharmacy teams to support carers. Support from healthcare professionals for carers is a priority for NHS England. The resource can be accessed from the PSNC website. 

  • Breakyl side effects

    3 FEB 2015 13:27

    The summary of product characteristics of Breakyl (fentanyl: Meda) has been updated to include the following adverse reactions: fall, flushing and hot flush, diarrhoea, fatigue, respiratory depression, malaise, peripheral oedema, convulsion, hallucination. In addition it is now contraidndicated in treatment of acute pain other than breakthrough pain.

  • Adherence to glucose lowering therapies in diabetes patients falls following a cancer diagnosis, new research finds

    Adherence to diabetes treatments falls after a cancer diagnosis Subscription

    3 FEB 2015 12:22

    Adherence to glucose lowering therapies in diabetes patients falls following a cancer diagnosis.

  • Iclusig warnings

    3 FEB 2015 12:16

    The summary of product characteristics of Iclusig (ponatinib; Ariad) now warns that there is a risk of vascular occlusive events, congestive heart failure and haemorrhage. There is also new information relating to assessment of cardiovascular status and alternative treatment.

  • Maternal, newborn and child health webinars

    3 FEB 2015 12:16

    The International Pharmaceutical Federation’s (FIP) Community Pharmacy Section (CPS) is launching a series of four free webinars to support pharmacists’ efforts in maternal, newborn and child health. The first webinar, which takes place on 18 February 2015 at 11am CET, will give a background to maternal, newborn and child health (MNCH) in the context of the United Nations’ Millennium Development Goals, but particularly in terms of delivering ...

  • Elvanse side effects and administration

    3 FEB 2015 12:15

    The summary of product characteristics for Elvanse (lisdexamfetamine; Shire) has been updated to include constipation and Raynaud’s phenomenon as undesirable effects and anorexia deleted as an undesirable effect. The frequencies of nine other undesirable effects have been updated. In addition there have been changes to the poslogy and administration and interactions sections.  

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.